Advertisement
Organisation › Details
Ferring Arzneimittel GmbH
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth. Founded in 1950, Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. *
Start | 1997-01-01 existent | |
Group | Ferring (Paulsen Foundation) (Group) | |
Industry | pharmaceutical | |
Person | Daglinger, Birgit (Ferring 201210 Managing Director of Ferring Arzneimittel GmbH) | |
Region | Kiel | |
Country | Germany | |
Street | 7 Fabrikstr. | |
City | 24103 Kiel | |
Tel | +49-431-5852-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Ferring Pharmaceuticals S.A.. (4/5/18). "Press Release: Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.". Saint-Prex & Roseville, MN. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Ferring (Paulsen Foundation) (Group)
- [1] Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck....
- [2] Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris....
- [3] Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA....
- [4] Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC....
- [5] Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA....
- [6] Ferring Pharmaceuticals S.A.. (4/5/18). "Press Release: Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.". Saint-Prex & Roseville, MN....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top